According to a recent retrospective study at Oregon Health & Sciences University, appropriately selected patients 65 or older who underwent septal myectomy for obstructive hypertrophic cardiomyopathy (HOCM) have surgical outcomes similar to younger patients. Therefore, older age should NOT be an automatic disqualifier for myectomy. All potential treatments for outflow tract obstruction should be considered, with age being only one of many factors influencing the decision.
Could this minimally invasive procedure prove to be a viable alternative to septal myectomy or alcohol ablation for septal reduction?
Doctors at Minneapolis Heart Institute are planning a larger, multi-center trial to test the viability of this procedure as a larger scale treatment for HCM.
According to a recent article in the British Cardiac Society’s Heart, HCM patients have a higher complication rate associated with unrelated non-cardiac surgeries than non-HCM patient undergoing similar procedures. Hence, HCM patients undergoing surgery should receive increased attention during and after surgery.